Latest Drugs, Latest Approval in Calcimimetics

What are Calcimimetics?

Calcimimetics reduce levels of parathyroid hormone and serum calcium. The main regulator of the parathyroid formation and release is calcium-sensing receptors on the cells of the parathyroid gland. Calcimimetics act to increase the sensitivity of the calcium-sensing receptor to extracellular calcium and therefore there is a decrease in parathyroid hormone and a decrease in serum calcium levels.

Name Updated
Cinacalcet (Cinacalcet [ sin-ah-cal-set ]) 16-Aug-2023
Etelcalcetide (Etelcalcetide [ e-tel-kal-se-tide ]) 11-Aug-2023
Sensipar (Cinacalcet [ sin-ah-cal-set ]) 14-Jul-2023
Parsabiv (Etelcalcetide [ e-tel-kal-se-tide ]) 13-Jul-2023